UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis

European urology, 2004-06, Vol.45 (6), p.773-780

2004

Volltextzugriff (PDF)

The relationship between sexual life and urinary condition in the French community

Journal of clinical epidemiology, 1996-10, Vol.49 (10), p.1171-1176

1996

Volltextzugriff (PDF)

Characteristics of patients presenting with LUTS/BPH in six European countries

European urology, 2006-09, Vol.50 (3), p.555-562

2006

Volltextzugriff (PDF)

In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line

The Prostate, 2001-01, Vol.46 (1), p.2-10

2001

Volltextzugriff (PDF)

A 3 TROCAR TECHNIQUE FOR TRANSPERITONEAL LAPAROSCOPIC NEPHRECTOMY

The Journal of urology, 1999-05, Vol.161 (5), p.1530-1532

1999

Volltextzugriff (PDF)

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

European urology, 2002-05, Vol.41 (5), p.497-507

2002

Volltextzugriff (PDF)

Spontaneous Rupture of Orthotopic Detubularized Ileal Bladder Replacement: Report of 5 Cases

The Journal of urology, 1997-09, Vol.158 (3), p.798-800

1997

Volltextzugriff (PDF)

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

Expert opinion on pharmacotherapy, 2004-10, Vol.5 (10), p.2171-2179

2004

Volltextzugriff (PDF)

Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon ®), Tamsulosin or Finasteride

European urology, 2005-08, Vol.48 (2), p.269-276

2005

Volltextzugriff (PDF)

Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer

BJU international, 2007-07, Vol.100 Suppl 1, p.1-5

2007

Volltextzugriff (PDF)

VEGF and VEGFR‐1 are coexpressed by epithelial and stromal cells of renal cell carcinoma

Cancer, 2008-01, Vol.112 (2), p.433-442

2008

Volltextzugriff (PDF)

Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic, or laser lithotripsy

Journal of endourology, 1994-08, Vol.8 (4), p.293-299

1994

Volltextzugriff (PDF)

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

The Prostate, 1996-10, Vol.29 (4), p.231-240

1996

Volltextzugriff (PDF)

Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life

Journal of endourology, 2007-02, Vol.21 (2), p.173

2007

Volltextzugriff (PDF)

Management of Pelvic Stones Larger than 20 mm: Laparoscopic Transperitoneal Pyelolithotomy or Percutaneous Nephrolithotomy?

Urologia internationalis, 2005-01, Vol.75 (4), p.322-326

2005

Volltextzugriff (PDF)

Corrigendum to “The Prostate Cancer Prevention Trial and Its Implications for Clinical Practice: A European Consensus” [European Urology Supplements 5 (2006) 640–646]

European urology, 2006-12, Vol.50 (6), p.1384

2006

Volltextzugriff (PDF)

Introduction

European urology, 1997-02, Vol.32 (Suppl 2), p.33-33

Teillac, Pierre

1997

Volltextzugriff (PDF)

Non‐invasive molecular detection of bladder cancer recurrence

International journal of cancer, 2002-09, Vol.101 (3), p.293-297

2002

Volltextzugriff (PDF)

Expert opinion on 6‐monthly luteinizing hormone‐releasing hormone agonist treatment with a novel depot delivery system for prostate cancer

BJU international, 2007-07, Vol.100 (s1), p.1-5

2007

Volltextzugriff (PDF)

Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia

Journal of endourology, 1999-03, Vol.13 (2), p.127-130

1999

Volltextzugriff (PDF)

Infrequent Microsatellite Instability in Urothelial Cell Carcinoma of the Bladder in Young Patients

European urology, 2006-04, Vol.49 (4), p.685-690

2006

Volltextzugriff (PDF)

Impact of Symptoms of Prostatism on Level of Bother and Quality of Life of Men in the French Community

The Journal of urology, 1995-03, Vol.153 (3), p.669-673

1995

Volltextzugriff (PDF)

Relief of BPO or Improvement in Quality of Life?

European urology, 1998-01, Vol.34 (Suppl 2), p.3-9

Teillac, Pierre

1998

Volltextzugriff (PDF)

Chemotherapeutic Prevention Studies of Prostate Cancer

The Journal of urology, 2004-02, Vol.171 (2), p.S10-S14

2004

Volltextzugriff (PDF)

Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer

Virchows Archiv : an international journal of pathology, 2006-08, Vol.449 (2), p.238-243

2006

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(75)
Science & Technology
(75)
Humans
(63)
Male
(51)
Biological And Medical Sciences
(49)
Medical Sciences
(48)
Urology & Nephrology
(46)
Female
(37)
Middle Aged
(34)
Aged
(29)
Nephrology. Urinary Tract Diseases
(24)
Adult
(20)
Sciences Biologiques Et Medicales
(19)
Sciences Medicales
(19)
Tumors Of The Urinary System
(19)
Urinary Tract. Prostate Gland
(18)
Aged, 80 And Over
(13)
Nephrologie. Maladies Des Voies Urinaires
(12)
Treatment Outcome
(12)
Animals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients—PERMAL Study Subset Analysis

The relationship between sexual life and urinary condition in the French community

Characteristics of patients presenting with LUTS/BPH in six European countries

In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line

A 3 TROCAR TECHNIQUE FOR TRANSPERITONEAL LAPAROSCOPIC NEPHRECTOMY

Comparison of a Phytotherapeutic Agent (Permixon) with an α-Blocker (Tamsulosin) in the Treatment of Benign Prostatic Hyperplasia: A 1-Year Randomized International Study

Spontaneous Rupture of Orthotopic Detubularized Ileal Bladder Replacement: Report of 5 Cases

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

Evaluation of Male Sexual Function in Patients with Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Treated with a Phytotherapeutic Agent (Permixon ®), Tamsulosin or Finasteride

Expert opinion on 6-monthly luteinizing hormone-releasing hormone agonist treatment with the single-sphere depot system for prostate cancer

VEGF and VEGFR‐1 are coexpressed by epithelial and stromal cells of renal cell carcinoma

Ureteral and bladder lesions after ballistic, ultrasonic, electrohydraulic, or laser lithotripsy

Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients

Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: prospective evaluation of patient's quality of life

Management of Pelvic Stones Larger than 20 mm: Laparoscopic Transperitoneal Pyelolithotomy or Percutaneous Nephrolithotomy?

Corrigendum to “The Prostate Cancer Prevention Trial and Its Implications for Clinical Practice: A European Consensus” [European Urology Supplements 5 (2006) 640–646]

Introduction

Non‐invasive molecular detection of bladder cancer recurrence

Expert opinion on 6‐monthly luteinizing hormone‐releasing hormone agonist treatment with a novel depot delivery system for prostate cancer

Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia

Infrequent Microsatellite Instability in Urothelial Cell Carcinoma of the Bladder in Young Patients

Impact of Symptoms of Prostatism on Level of Bother and Quality of Life of Men in the French Community

Relief of BPO or Improvement in Quality of Life?

Chemotherapeutic Prevention Studies of Prostate Cancer

Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer

Suchergebnisse filtern